Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas Groot Koerkamp

Showing results (461-470 of 487) with videos related to

Pageof 49
Sort By:
JAMA Surgery|October 8, 2025
Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialCaro L Bruna, Jony van Hilst, Maarten Korrel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic modelsAmmar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Trials|April 9, 2017
Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trialThijs de Rooij, Jony van Hilst, Jantien A Vogel, et al.
Annals of Surgery|December 15, 2017
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.
Trials|September 10, 2021
Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trialJony van Hilst, Maarten Korrel, Sanne Lof, et al.
Journal of the National Cancer Institute|September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinomaAmmar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 11, 2024
Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implicationsWills F Filipe, Florian E Buisman, Stijn Franssen, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
United European Gastroenterology Journal|July 29, 2025
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)Mohammad Abu Hilal, Bas A Uijterwijk, Daniël H L Lemmers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 TrialRuth A L Willems, Aniek E van Diepen, Esther N Dekker, et al.
Pageof 49

Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
JAMA Surgery|October 8, 2025
Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialCaro L Bruna, Jony van Hilst, Maarten Korrel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic modelsAmmar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Trials|April 9, 2017
Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trialThijs de Rooij, Jony van Hilst, Jantien A Vogel, et al.
Annals of Surgery|December 15, 2017
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.
Trials|September 10, 2021
Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trialJony van Hilst, Maarten Korrel, Sanne Lof, et al.
Journal of the National Cancer Institute|September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinomaAmmar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 11, 2024
Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implicationsWills F Filipe, Florian E Buisman, Stijn Franssen, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
United European Gastroenterology Journal|July 29, 2025
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)Mohammad Abu Hilal, Bas A Uijterwijk, Daniël H L Lemmers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 TrialRuth A L Willems, Aniek E van Diepen, Esther N Dekker, et al.
Pageof 49